Inhibitory potential of subpopulations of CD8+ T cells in HIV-1-infected elite suppressors

Journal of Virology

Volumn 86, Issue 24, 2012, Pages 13679-13688

  Buckheit III, Robert W ^a   Salgado, Maria ^a   Silciano, Robert F ^a   Blankson, Joel N ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL ACTIVITY; CELL ISOLATION; CELL KINETICS; CELL SELECTION; CONTROLLED STUDY; DISEASE COURSE; EFFECTOR CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNOSTIMULATION; IN VITRO STUDY; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SUPPRESSOR CELL; T LYMPHOCYTE SUBPOPULATION; TARGET CELL; VIRUS INHIBITION; VIRUS REPLICATION;

CD8-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84870686389     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02439-12     Document Type: Article

References (57)

1. Addo MM, et al. 2003. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J. Virol. 77:2081-2092.
2. Almeida JR, et al. 2007. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J. Exp. Med. 204:2473-2485. doi:10.1084/jem.20070784.
3. Bailey JR, et al. 2008. Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor. J. Virol. 82:7395-7410. doi:10.1128/JVI.00800-08.
4. Betts MR, et al. 2001. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection. J. Virol. 75:11983-11991. doi: 10.1128/JVI.75.24.11983-11991.2001.
5. Betts MR, et al. 2006. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107:4781-4789. doi: 10.1182/blood-2005-12-4818.
6. Blankson JN. 2011. The study of elite controllers: a pure academic exercise or a potential pathway to an HIV-1 vaccine? Curr. Opin. HIV AIDS 6:147-150. doi:10.1097/COH.0b013e3283457868.
7. Buckheit RW, III, et al. 2012. Host factors dictate control of viral replication in two HIV-1 controller/chronic progressor transmission pairs. Nat. Commun. 3:716. doi:10.1038/ncomms1697.
8. Carbone J, Gil J, Benito JM, Munoz-Fernandez A, Fernandez-Cruz E. 2001. Elevated levels of CD4+CD7- T cells in HIV infection add to the prognostic value of low CD4 T cell levels and HIV-1-RNA quantification. AIDS 15:2459-2460.
9. Catano G, et al. 2008. HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles. PLoS One 3:e3636. doi:10.1371/journal.pone.0003636.
10. Champagne P, et al. 2001. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410:106-111. doi:10.1038/35065118.
11. Dalmasso C, et al. 2008. Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: the ANRS Genome Wide Association 01 Study. PLoS One 3:e3907. doi:10.1371/journal. pone.0003907.
12. Ehl S, Klenerman P, Aichele P, Hengartner H, Zinkernagel RM. 1997. A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitro. Eur. J. Immunol. 27:3404-3413. doi:10.1002/eji.1830271240.
13. Elahi S, et al. 2011. Protective HIV-specific CD8+ T cells evade Treg cell suppression. Nat. Med. 17:989-995. doi:10.1038/nm.2422.
14. Emu B, et al. 2008. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control. J. Virol. 82:5398-5407. doi:10.1128/JVI.02176-07.
15. Faint JM, et al. 2001. Memory T cells constitute a subset of the human CD8+CD45RA+pool with distinct phenotypic and migratory characteristics. J. Immunol. 167:212-220.
16. Fellay J, et al. 2007. A whole-genome association study of major determinants for host control of HIV-1. Science 317:944-947. doi:10.1126/ science.1143767.
17. Ferre AL, et al. 2009. Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control. Blood 113:3978-3989. doi:10.1182/blood-2008-10-182709.
18. Freel SA, et al. 2010. Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination. J. Virol. 84:4998-5006. doi:10.1128/JVI.00138-10.
19. Friedrich TC, et al. 2007. Subdominant CD8+ T-cell responses are involved in durable control of AIDS virus replication. J. Virol. 81:3465-3476. doi:10.1128/JVI.02392-06.
20. Giorgi JV, et al. 1993. Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. J. Acquir. Immune Defic. Syndr. 6:904-912.
21. Han Y, et al. 2008. The role of protective HCP5 and HLA-C associated polymorphisms in the control of HIV-1 replication in a subset of elite suppressors. AIDS. 22:541-544. doi:10.1097/QAD.0b013e3282f470e4.
22. Hansen SG, et al. 2011. Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 473:523-527. doi:10.1038/nature10003.
23. Hersperger AR, Migueles SA, Betts MR, Connors M. 2011. Qualitative features of the HIV-specific CD8+T-cell response associated with immunologic control. Curr. Opin. HIV AIDS 6:169-173. doi:10.1097/COH.0b013e3283454c39.
24. Hersperger AR, et al. 2010. Perforin expression directly ex vivo by HIVspecific CD8 T-cells is a correlate of HIV elite control. PLoS Pathog. 6:e1000917. doi:10.1371/journal.ppat.1000917.
25. International HIV Controllers Study. 2010. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 330:1551-1557. doi:10.1126/science.1195271.
26. Jagannathan P, et al. 2009. Comparisons of CD8+ T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, phenotype, and interleukin-2 responsiveness. J. Virol. 83:2728-2742. doi:10.1128/JVI.02128-08.
27. Kiepiela P, et al. 2007. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat. Med. 13:46-53. doi:10.1038/nm1520.
28. Killian MS, Johnson C, Teque F, Fujimura S, Levy JA. 2011. Natural suppression of human immunodeficiency virus type 1 replication is mediated by transitional memory CD8+T cells. J. Virol. 85:1696-1705. doi:10.1128/JVI.01120-10.
29. Lambotte O, et al. 2005. HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. Clin. Infect. Dis. 41:1053-1056. doi:10.1086/433188.
30. Leslie AJ, et al. 2004. HIV evolution: CTL escape mutation and reversion after transmission. Nat. Med. 10:282-289. doi:10.1038/nm992.
31. Lichterfeld M, et al. 2004. HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8(+) T cells producing both interferongamma and tumor necrosis factor-alpha. Blood 104:487-494. doi:10.1182/blood-2003-12-4341.
32. Limou S, et al. 2009. Genomewide association study of an AIDSnonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). J. Infect. Dis. 199:419-426. doi:10.1086/596067.
33. Liu Z, et al. 1998. CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 18:332-340.
34. Liu Z, et al. 1997. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 16: 83-92.
35. Martinez-Picado J, et al. 2006. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J. Virol. 80:3617-3623. doi:10.1128/JVI.80.7.3617-3623.2006.
36. Migueles SA, et al. 2002. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat. Immunol. 3:1061-1068. doi:10.1038/ni845.
37. Migueles SA, et al. 2008. Lytic granule loading of CD8+T cells is required for HIV-infected cell elimination associated with immune control. Immunity 29:1009-1021. doi:10.1016/j.immuni.2008.10.010.
38. Migueles SA, et al. 2000. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc. Natl. Acad. Sci. U. S. A. 97:2709-2714. doi:10.1073/pnas.050567397.
39. Miller JD, et al. 2008. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity 28:710-722. 10.1016/j.immuni.2008.02.020.
40. Ndhlovu ZM, et al. 2012. Elite controllers with low to absent effector CD8+ T cell responses maintain highly functional, broadly directed central memory responses. J. Virol. 86:6959-6969. doi:10.1128/JVI.00531-12.
41. Ockulicz J, Lambotte O. 2011. 1. Epidemiology and clinical characteristics of elite controllers. Curr. Opin. HIV AIDS 6:163-168.
42. O'Connell KA, Rabi SA, Siliciano RF, Blankson JN. 2011. CD4+ T cells from elite suppressors are more susceptible to HIV-1 but produce fewer virions than cells from chronic progressors. Proc. Natl. Acad. Sci. U. S. A. 108:E689-E698. doi:10.1073/pnas.1108866108.
43. O'Doherty U, Swiggard WJ, Malim MH. 2000. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J. Virol. 74:10074-10080.
44. Pandrea I, et al. 2011. Functional cure of SIVagm infection in rhesus macaques results in complete recovery of CD4+T cells and is reverted by CD8+ cell depletion. PLoS Pathog. 7:e1002170. doi:10.1371/journal.ppat.1002170.
45. Pereyra F, et al. 2008. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J. Infect. Dis. 197:563-571. doi:10.1086/526786.
46. Rabi SA, et al. 2011. Unstimulated primary CD4+ T cells from HIV-1-positive elite suppressors are fully susceptible to HIV-1 entry and productive infection. J. Virol. 85:979-986. doi:10.1128/JVI.01721-10.
47. Rolland M, et al. 2008. Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads. PLoS One 3:e1424. doi:10.1371/journal.pone.0001424.
48. Sáez-Cirión A, et al. 2007. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc. Natl. Acad. Sci. U. S. A. 104:6776-6781. doi:10.1073/pnas.0611244104.
49. Sáez-Cirión A, et al. 2009. Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses. J. Immunol. 182:7828-7837. doi:10.4049/jimmunol.0803928.
50. Sajadi MM, et al. 2009. Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors. J. Acquir. Immune Defic. Syndr. 50: 403-408. doi:10.1097/QAI.0b013e3181945f1e.
51. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708-712. doi:10.1038/44385.
52. Sandberg JK, Fast NM, Nixon DF. 2001. Functional heterogeneity of cytokines and cytolytic effector molecules in human CD8+ T lymphocytes. J. Immunol. 167:181-187.
53. van Manen D, et al. 2009. Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection. AIDS 23:19-28. doi:10.1097/QAD.0b013e32831db247.
54. Wills MR, et al. 1999. Human virus-specific CD8+ CTL clones revert from CD45ROhigh to CD45RAhigh in vivo: CD45RAhighCD8+ T cells comprise both naive and memory cells. J. Immunol. 162:7080-7087.
55. Wills MR, et al. 2002. Identification of naive or antigen-experienced human CD8(+) T cells by expression of costimulation and chemokine receptors: analysis of the human cytomegalovirus-specific CD8(+) T cell response. J. Immunol. 168:5455-5464.
56. Wilson JD, et al. 1998. Oligoclonal expansions of CD8(+) T cells in chronic HIV infection are antigen specific. J. Exp. Med. 188:785-790.
57. Yang H, et al. 2012. Antiviral inhibitory capacity of CD8+T cells predicts the rate of CD4+T-cell decline in HIV-1 infection. J. Infect. Dis. 206:552-561. doi:10.1093/infdis/jis379.